| INTRODUCTION
Deficiency of 5-alpha reductase type 2 (5α-R2D) is a rare, autosomal recessive 46,XY DSD that results in a reduced ability to convert testosterone to its more potent metabolite, dihydrotestosterone (DHT). Encoded by SRD5A2 (steroid-5-alpha reductase 2, MIM 607306), 5α-R2D results in undervirilized genitalia at birth and the possibility to virilize at puberty (Imperato-McGinley, Guerrero, Gautier, & Peterson, 1974) . Initially recognized in large families in the Dominican Republic and Papua New Guinea, 5α-R2D also occurs outside of these ethnic groups. The overall incidence is unknown.
During embryogenesis, the fetus is exposed to normal levels of testosterone, the androgen responsible for typical development of male testes and ejaculatory ducts. In contrast, development of the prostate and typical male external genitalia is dependent on DHT; DHT deficiency results in undervirilization. Depending on the degree of 5-alpha reductase type 2 activity, affected individuals are exposed to varying amounts of DHT in utero. This results in phenotypic variability from hypospadias or micropenis in the most virilized individuals to external genitalia that appear normal female in the most severe cases (Imperato-McGinley et al., 1974; Maimoun et al., 2011) .
Depending on the degree of 5-alpha reductase type 2 activity, affected individuals are exposed to varying amounts of DHT in utero. This results in phenotypic variability from hypospadias or micropenis in the most virilized individuals to external genitalia that appear normal female in the most severe cases.
Sex of rearing is assigned based on diagnosis, genital appearance, surgical options, potential fertility and need for lifelong hormonal therapy (Hughes, Houk, Ahmed, & Lee, 2006) . Though sex of rearing is assigned to address anatomic and hormonal needs, it also provides families with a social and cultural framework to raise their child before the child is able to express gender identity. Given the severity of the undervirilization in 5α-R2D at birth, affected individuals have historically been raised female (Kolesinska et al., 2014) . More recent studies showing that over half of patients who underwent a virilizing puberty because their gonads were not removed adopted a male gender identity in adulthood have challenged this practice (Costa, Domenice, Sircili, Inacio, & Mendonca, 2012; Maimoun et al., 2011) . Improved phenotypic awareness and more comprehensive molecular diagnostics has led to earlier diagnosis and broadened the phenotypic understanding of several known DSDs, including 5α-R2D. This presents a challenging clinical and ethical dilemma for parents and medical providers when diagnosis occurs before the patient's ability to express gender identity-when both treatment (gonadectomy) and the lack thereof (which can lead to a virilizing puberty) can lead to irrevocable changes (Flück et al., 2011) .
The goals of sex assignment of rearing are to assign a sex with the greatest likelihood for concordant gender identity in adulthood.
Gender identity develops over time. It is based on sex chromosomes, androgen exposure, psychosocial development, cultural expectations, family dynamics, and social situation (Sandberg, Gardner, & CohenKettenis, 2012) . While young children can recognize gender, gender identity is likely not fixed until after puberty (Cohen-Kettenis, 2005) .
The factors that contribute to gender identity are complex and difficult to report; there are few clinical and laboratory indicators of adult gender identity in 5α-R2D.
The goals of sex assignment of rearing are to assign a sex with the greatest likelihood for concordant gender identity in adulthood. Gender identity develops over time. It is based on sex chromosomes, androgen exposure, psychosocial development, cultural expectations, family dynamics, and social situation.
Herein, we describe five patients with 5α-R2D and severely undervirilized external genitalia, who presented over a 12-year period.
All parents strongly desired to raise the child as female given external genital appearance, poor predicted surgical outcome, and (when present) the patient's expressed gender identity. Parents desired gonadectomy to reinforce sex of rearing assignment, prevent virilization at puberty, and to alleviate parental distress. These cases illustrate the complicated decision-making process of sex of rearing assignment in the most severe phenotypic presentation of 5α-R2D
and highlight the urgent need for clinical investigation into predictors of adult gender identity. She had a very small clitoris with a separate urethral opening and a posterior introitus (Figure 1 ). Masses were palpated in the labioscrotal folds bilaterally, prompting referral to our DSD team.
| CLINICAL PRESENTATION
After karyotype, molecular workup included FISH, which confirmed the presence of sex-determining region (SRY) and single-gene sequencing of the androgen receptor gene (AR), which was normal (Table 1) . Ultrasound suggested the presence of a bicornuate uterus and masses in the labioscrotal folds were considered consistent with testes with visualized epididymis. Given the presumed presence of male and female structures, there was concern for dysplastic gonads and the recommendation was made for laparoscopic evaluation and gonadectomy.
However, at the time of laparoscopy at age 8 months, no Mullerian structures were identified. Vaginal vault measured 2.5 × 3 centimeters and no cervix was visualized. Masses in labial folds measured 1 × 0.4 × 0.7 cm (right) and 0.9 × 0.5 × 0.7 cm (left) and were consistent with normal testes, confirmed on surgical biopsy. Given these findings, testes were left in place.
When the patient returned to clinic at age two-and-a half, she was reevaluated by our DSD team, including our child psychologist. She fully identified as female. The family noted little difference in her behavior and interests compared to her two older sisters. Testes retracted into the inguinal canal around age 18 months and were apparent only by palpation. 5α-R2D was considered and SRD5A2 was sequenced. This identified homozygous pathogenic variants in SRD5A2 (p. Pro212Arg), which confirmed a diagnosis of 5α-R2D.
This variant has previously been reported in families of Mexican descent (Vilchis et al., 2010) . Case 1 is currently 7 years old and fully identifies as female. The family did not have the means to independently pursue a court order for gonadectomy and the patient retains her testes. She is followed closely by our child psychologist and will follow-up with the full DSD team prior to puberty.
FIGURE 1 All patients had bifid labioscrotal folds with minimal rugae, little or no hyperpigmentation, separate urethra and introitus, no clitoromegaly and normal placement of the anus Following discussions shortly after birth, a presumed diagnosis of AIS, and probable need for significant surgical reconstruction if raised as a male, the parents committed to raising the child as female. The infant was referred to Pediatric Endocrinology at our center for presumed AIS and seen at 1 month of age. At this time, pelvic ultrasound was not able to identify a uterus. Single-gene AR sequencing was normal, making a diagnosis of AIS unlikely (Table 1 ). An hCG stimulation test performed at 10 months of age revealed an elevated T/DHT ratio (>50 at Days 3, 5, and 6 following hCG injection), a level considered diagnostic of 5α-R2D. After diagnosis of 5α-R2D was achieved biochemically, the family elected to pursue gonadectomy due to concern for virilization at puberty. The patient underwent gonadec- Given her sister's diagnosis, it was presumed this child also had 5α-R2D and parents decided to raise her as female. The parents chose to proceed with gonadectomy and felt comfortable with this decision due to her sister's diagnosis and treatment. Gonadectomy was performed at age 7 months and revealed normal appearing, immature testicles with well-developed epididymis and vas deferens. Vaginoscopy performed in the operating room revealed a short, blind-ending vaginal pouch. SRD5A2 sequencing revealed biallelic pathogenic variants in exon 4, p. Asn193Ser and p. His231Arg. Targeted genetic testing in Case 2 confirmed the same two pathogenic variants.
Cases 2 and 3 are currently 7 and 3 years old, respectively, and otherwise healthy. Both patients identify with female gender. The 7-year-old is treated by child psychiatry for behavioral problems, including aggressive behavior. The family is seen every 2-3 years for DSD follow-up and will be introduced to our adolescent gynecologist when the patients reach pubertal age.
| CASE FOUR
Case 4 was the third child born at term to a Caucasian couple following an unremarkable pregnancy. A 20-week ultrasound suggested female external genitalia. After birth, the neonate was noted to have palpable masses in the labioscrotal folds bilaterally and was transferred to our center for further evaluation and management. The external genitalia showed smooth labioscrotal folds with palpable gonads, no clitoromegaly, and a single opening below the clitoris. Pelvic ultrasound was unable to identify a uterus. After karyotype, sequential single-gene sequencing of NR5A1 and AR genes was normal. The T/DHT ratio was slightly high at 13 hr of life at 15.2. An hCG stimulation test at age 1 month revealed a T/DHT ratio of 19.2 at day 6 following hCG injection, which was high, but not considered diagnostic based on the knowledge at that time (Table 1) .
Given the external genital phenotype, parents strongly preferred to raise the child with a female sex of rearing. Gonadectomy was requested to reinforce the female sex of rearing assignment and alleviate parental anxiety regarding the presence of palpable gonads in the labioscrotal folds. Gonadectomy was performed at age 18 months. The child is currently 9 years old and otherwise healthy. She continues to identify as female. The plan is to return to DSD clinic for care around age 10, prior to puberty, to initiate discussions about hormone replacement therapy and to establish care with adolescent gynecology with the anticipated need for vaginal management in the future.
| CASE FIVE
Case 5 was born prematurely to an African-American couple.
Pregnancy was complicated by maternal drug use and prematurity.
At birth, palpable gonads were present in labioscrotal folds bilaterally.
There was no clitoromegaly and the separate introital opening was unremarkable. Testosterone, DHT, and 17-hydroxyprogesterone were all elevated by outside report. Pelvic ultrasound was unable to identify a uterus and the patient was given a working clinical diagnosis of AIS. Post-operatively, the patient was lost to follow-up until age 9, when there was a change in her caregiver; biological parents were no longer involved. Neither the new caregiver nor the patient had any knowledge about the patient's prior medical care or evaluation, so disclosure and education were a focus of the visit. Estrogen therapy was initiated and molecular evaluation of AR and SRD5A2 was pursued (Table 1) . This revealed two known pathogenic variants in SRD5A2
(p. Glu57Gln, p. Gly183Ser) and the patient was diagnosed with 5α-R2D.
The patient was again lost to follow-up from ages 10-12. Estrogen therapy was self-discontinued from ages 11-12, and recently restarted. The patient is currently 12 years old and identifies as female. Her guardian reports the patient had a more "tomboyish" and "aggressive" demeanor after estrogen therapy was suspended. The patient will continue to follow with the DSD team. She was referred to adolescent gynecology to establish care for eventual vaginal management.
| DISCUSSION
These cases illustrate the complexities of diagnosis, sex assignment, and management of patients with 5α-R2D and highlight the urgent need for investigation into clinical markers of adult gender identity.
Improved recognition and molecular diagnostics have allowed for earlier diagnosis, broadened the phenotypic understanding, and increased awareness that 5α-R2D exists outside of specific populations. Previously, these patients frequently received a clinical diagnosis of partial or complete androgen insensitivity syndrome (PAIS, CAIS) or did not come to medical attention until virilization at puberty (Berra et al., 2011; Cohen-Kettenis, 2005; Costa et al., 2012; Imperato-McGinley et al., 1974; Maimoun et al., 2011) . We anticipate early diagnosis will continue to expand with the widespread adoption of non-invasive prenatal screening, which reports a sex chromosome complement and may highlight genotype-phenotype discordance in severely affected individuals at birth. While early diagnosis can assist with medical management, it also presents unique challenges.
Improved recognition and molecular diagnostics have allowed for earlier diagnosis, broadened the phenotypic understanding, and increased awareness that 5α-R2D exists outside of specific populations.
Parents (and later patients) often experience a great deal of stress with a diagnosis of 46,XY DSD (Herdt & Davidson, 1988; Hughes et al., 2006; Maimoun et al., 2011; Sandburg et al., 2012; Suorsa et al., 2015; Thyen, Lux, Jürgensen, Hiort, & Köhler, 2014) . Sex assignment in 46,XY DSD due to defects of androgen biosynthesis is particularly challenging given the potential for virilization at puberty. Exposure to varying amounts of androgens in utero and at puberty may affect adult gender identity, though this is not easily measured or assessed (Wilson, 2001) . Both male and female adult gender identities have been reported in patients who have undergone a virilizing puberty (Berra et al., 2011; Cohen-Kettenis, 2005; Houk, Damiani, & Lee, 2005; Maimoun et al., 2011) . Systematic review of adult gender identity in patients raised as females with early gender-enforcing surgery is lacking; it is not known if early surgery leads to higher rates of concordant female adult gender identity. Consensus guidelines for sex assignment in 5α-R2D are non-directive and rely on considerable clinical judgment (Douglas et al., 2010; Hughes et al., 2006) . Therefore, it is critical that patients are evaluated in a specialized center with expertise in evaluating and managing patients with DSD.
Overall, 5α-R2D is rare and has a broad phenotypic spectrum.
The severe phenotype we describe makes up less than 10% of reported cases (Maimoun et al., 2011) . The literature on 5α-R2D is largely reflective of the most common, characteristic phenotypic presentations and may not be generalizable to patients with a severe phenotype. Genotype-phenotype correlations have been shown for some recurrent variants, though intra-familial differences in phenotype and sex assignment continue to make definitive genotype-phenotype correlations challenging (Vilchis et al., 2010) .
The patients in this case series were evaluated over a 12-year period and reflect clinical knowledge and molecular diagnostics available at the time. Today, we consider 5α-R2D as part of the differential diagnosis of CAIS or PAIS for any patient with 46,XY chromosomal analysis, normal to high testosterone and ambiguous or undervirilized genitalia. Current molecular workup would include karyotype with FISH for SRY or microarray followed by panel testing selected by phenotype.
The practice of early genital surgery and sex assignment has shifted in the past decade. Prior to 1990, 14% of patients with 46,XY DSD due to androgen biosynthesis defect were assigned male, compared to 54% after 1999 (Kolesinska et al., 2014) . Various factors contribute to this trend, including shifting cultural and societal views, improved surgical reconstruction techniques, and a better understanding of the potential fertility, oncogenic risk and adult gender identity in this cohort (Hughes et al., 2006; Kolesinska et al., 2014) .
Though evidence is lacking, it was commonly believed in practice that cosmetic genital surgery performed prior to the child's first birthday reduced parental anxiety and improved parent-child bonding (Hughes et al., 2006) . Though based on a small number of patients, oncogenic risk in patients with 5α-R2D who do not undergo orchiectomy is considered low and may be even lower in patients with biopsy-proven normal testes and corrected cryptorchidism (Hughes et al., 2006; Sasaki et al., 2003) . In the cases reported here, external genital appearance played a large role in parental and clinical decision-making.
All parents reported feeling highly distressed by the presence of gonads, even after gonads ascended into the inguinal canal and were minimally visible. Parents advocated for gonadectomy to reinforce their decision to raise the child as female, prevent virilization and reduce parental anxiety.
Fertility was a crucial consideration regarding gonadectomy for Case 1. Given the advanced reproductive technologies (ART) available today, the connotation of fertility continues to evolve. Fertility is defined as the ability to conceive a child and does not note whether interventions are required to achieve that end. Most patients affected with 5α-R2D have oligospermia, arrested spermatogenesis, or anatomic limitations that would require ART for conception (Kang, Imperato-McGinley, Zhu, & Rosenwaks, 2014) . In patients without 46, XY DSD, fertility is improved with corrected cryptorchidism.
Spontaneous conception has been reported in a single patient with 5α-R2D, though his phenotype was much less severe than those presented here (Nordenskjöld & Ivarsson, 1998 (Hughes et al., 2006) . The increased use of LHRH analogs to prevent pubertal progression in children with gender dysphoria suggest that this therapy can also be used in patients raised female with 5α-R2D in order to give them more time to participate in decision making regarding gonadectomy. Deferring surgery until puberty allows the child to express free will and provide assent. However, the ability of a child to recognize gender identity and make an irreversible decision about sexuality at an age when psychosocial aspects of sexual maturity and sexual identity are just emerging is unclear (Costa et 
| CONCLUSIONS
In conclusion, these five patients highlight the complexity of diagnosis and management for patients with 5α-R2D and severe undervirilization, particularly regarding the decision for early gonadectomy.
These cases illustrate the importance of considering the broad phenotypic spectrum of 5α-R2D in larger studies and consensus statements, as recommendations may not be generalizable to patients at the extremes of the phenotypic spectrum. Ongoing care from an experienced interdisciplinary DSD team is critical and should evolve to meet the changing needs of the patient and family. Given the lifelong consequences of irreversible surgery and virilization at puberty, investigation into outcomes and predictors of gender identity are urgently needed to help guide decisions about sex of rearing in patients diagnosed with 5α-R2D.
